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Does physician education of alternative therapies for obstructive sleep apnea 
improve utilization?
Colin Huntley MD
Jefferson Sleep Disorders Center – Thomas Jefferson University
Background
Conclusion
The rate of CPAP compliance has ranged from 29-
83% in the literature. Alternative strategies including 
oral appliances, body positioning devices, and surgery 
need to be considered for those patients intolerant to 
CPAP. 
In August 2014, we performed our first upper 
airway stimulator (UAS) insertion. This is a new 
technology for use in patients with OSA unable to 
tolerate CPAP that induces muscle tone at the base of 
tongue and palate during sleep, thus relieving 
obstruction. 
We hypothesize that after institution of a UAS 
program, sleep physician education, and readily 
available literature, the utilization of alternative 
therapies for patients unable to tolerate CPAP would 
improve.
We conducted a retrospective chart review of 
patients in the Jefferson Sleep Disorder Center (JSDC) 
consisting of 2 cohorts of patients. The first was a group 
of patients undergoing PSG in March, 2014 prior to 
institution of the UAS program. The second was a cohort 
of patients undergoing PSG in July 2016 after institution 
of the UAS program, positive initial results, readily 
available literature in the JSDC, and a physician in-
service including details of the procedure and outcome, 
quality of life, and complication rate data.
We collected demographic and PSG data. We 
then reviewed the electronic medical record and 
assessed the first and second followup at the JSDC for 
CPAP compliance data and referral for oral appliance, 
body positioning device, or surgical evaluation. 
CPAP remains the first line therapy for OSA. 
However, there are numerous alternative treatment 
options for those unable to tolerate CPAP and 
institution of a UAS program along with physician 
education can increase utilization of these therapies. 
Methods
196 patients underwent a sleep study in March 
2014 with 77 meeting inclusion criteria. 184 
patients underwent a sleep study in July 2016 
with 69 meeting inclusion criteria. There was no 
difference in gender, age, AHI, O2 Nadir, Epworth 
sleepiness score (ESS), percent days using CPAP 
at initial followup, compliance at initial followup, 
treatment AHI at initial followup, compliance at 
second followup, treatment AHI at second 
followup, or surgical referrals after 
noncompliance at second followup between the 
two groups.
There was a significant difference in time to 
initial followup (p<0.001). The proportion of 
patients sent for a surgical referral after initial 
followup was greater in those undergoing PSG in 
2016 and this approached significance (p=0.071). 
Results
March 2014 July 2017
Number of patients undergoing 
Sleep Study
196 184
Dx w OSA and Rx CPAP 118 110
Followed up/Inc criteria 77 69
2014 2016 p value
Gender 49M  28F 44M 25F
Age 54.70±12.29 55.20±13.10 0.623
AHI 26.13±22.48 31.20±26.16 0.470
Nadir 78.12%±10.42 79.24%±9.45 0.226
ESS 11±6.99 11.14±6.05 0.636
2014 2016 p value
Time to FU 143.99±206.73 103.79±99.09 <0.0001
% Days used 67.58%±32.37 77.20%±29.40 0.182
Usage per night 
(minutes)
226.31±178.24 281.38±164.56 0.541
Pressure 8.80±3.27 8.50±2.54 0.191
AHI 3.39±4.05 5.36±4.03 0.368
Compliance 36% 48% 0.026
2014 2016 p value
All referral 13 17 0.306
Positioning  Device 1 1 1
OAT 5 3 0.722
Surgery 7 13 0.071
